Antibody Evolution Machine

A new approach developed by Harvard Medical School researchers uses yeast to rapidly evolve synthetic antibody fragments called nanobodies with the aim to find variants that are effective at binding to selected antigens, including SARS-CoV-2. The antibodies are intended for use in diagnostic tests and disease treatments.

Read the full story:

Products You May Like

Articles You May Like

Study Finds New Effective Method To Help Reduce Alcohol Consumption
Newly discovered gene marker may lead to a precision treatment for pancreatic cancer
The Covid-19 emergency may end, but there’s no rule to say when the pandemic is over
Leading Causes Of Death In The US: Where Does COVID-19 Stand?
Medical School Application Mistakes | 6 Common Pre-Med Blunders

Leave a Reply

Your email address will not be published.